Rose Romano

Develop and implement tailored medical education programs for inflammatory bowel disease (IBD) based on HCP needs assessments.

• Collaborate with cross-functional partners (medical, compliance, commercial, PSP) to develop aligned strategies and lead of integrated brand team (IBT)
• Organize national symposia and congress-related educational activities with medical and Key Opinion Leaders (KOLs).
• Facilitate steering committees, faculty engagement, speaker coordination, field engagement with KOLs driving medical strategic vision.
• Monitor and evaluate program outcomes to continuously improve educational offerings and enhance HCP engagement.
• Review grants with compliance and lead discussions on committee.

• Designed and launched comprehensive medical educational programs for ADHD and Binge-Eating Disorder (BED), leveraging innovative interactive formats which reached over 3000 HCPs in one year.
• Built and maintained strong relationships with faculty, facilitating their involvement in program development and delivery for a national webinar series and an accredited program.
• Managed four external vendor partnerships to execute national and regional learning programs adhering to timelines and budget.
• Conducted regular feedback consultative sessions with HCPs to refine and adapt educational content to meet evolving needs.
• Collaborated with medical and commercial teams to ensure learning programs supported broader strategic objectives.

• Developed strategic regional medical plans for ON East and Atlantic territories, aligning with global publication plan.
• Delivered 16 impactful post-congress presentations to KOLs, enhancing their understanding of complex medical concepts and treatment options.
• Identified and cultivated three new speaker opportunities to expand the reach of educational initiatives.
• Supported the development of two national and three advisory boards, ensuring alignment with regional strategies and enhancing stakeholder engagement.

• Led National medical strategy for the solid tumors portfolio
• Developed MSL medical strategy, plan of action, and metrics
• Trained MSLs, developed slide decks and training materials
• Supported medical information questions from the field
• Led and provided guidance for national and regional advisory boards
• Internal medical expert for cross-functional teams
• Supported internal teams (e.g. sales, medical education, regulatory, market access) with medical expertise
• Discussed top scientific data with KOLs from Ontario East

• Successfully developed and filed one New Drug Submission (NDS), six Level I (SNDSs), 26 Level II (NCs), and 49 Level III/IV submissions to support seven products (pharmaceuticals and biologics) in the therapeutic areas of: cardiovascular, metabolic, gastrointestinal diseases, and oncology in eCTD
• Collaboratively worked with cross-functional SMEs to develop regulatory strategy and path forward with Health Canada for stem cell based therapy NDS
• Provided input and review of all labelling, promotional and non-promotional materials
• Regulatory lead and expert on brand team.

• Led and managed Health Canada review, attained best label globally, and earlier approval of the NINLARO® NDS
• Executed the dissemination of three Dear Healthcare Professional Letters
• Effectively provided regulatory guidance in the filing of clinical trial applications (CTAs) for oncology and vaccine pipeline products.
• Coordinated four pre-NDS meetings with Health Canada and managed post-meeting activities.